PARAMETRIC IMAGING OF THE RATE-CONSTANT K(I) USING [18FLUORO]-L-DOPA POSITRON EMISSION TOMOGRAPHY IN PROGRESSIVE SUPRANUCLEAR PALSY

被引:4
|
作者
CORDES, M
SNOW, BJ
MORRISON, S
SOSSI, V
RUTH, TJ
CALNE, DB
机构
[1] UNIV BRITISH COLUMBIA HOSP,CTR NEURODEGENERAT DISORDERS,VANCOUVER,BC,CANADA
[2] UNIV BRITISH COLUMBIA,TRIUMF,VANCOUVER V6T 1W5,BC,CANADA
关键词
POSITRON EMISSION TOMOGRAPHY; NEURODEGENERATIVE DISORDERS; PROGRESSIVE SUPRANUCLEAR PALSY;
D O I
10.1007/BF00602816
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Positron emission tomography (PET) studies using [18F]-L-dopa were carried out in 9 patients with supranuclear palsy and 13 controls. For quantification of PET data a rate constant K(i) was calculated for the radiotracer using a graphical method. Corrections for nonspecific activity were performed in both arterial plasma and brain tissue. The purpose of this study was to test the hypothesis that parametric images of the rate constant K mapping can be obtained on a pixel-by-pixel basis using an appropriate mathematical algorithm. K(i) values from these parametric images and the graphical approach were compared. Both correlated closely, with y = 0.013 + 0.947*x, r = 0.992 and y = - 0.052 + 1.048*x, r = 0.965 in patients and controls, respectively. Contrast measurements were also performed and showed a striking increase in contrast on parametric images. K mapping offers several advantages over the graphical approach, since parametric images are time-independent, i. e. one image represents the quantitative result of the study. In addition, parametric images of the rate constant are normalized to arterial plasma radioactivity and corrected for tissue metabolites. Thus, parametric images of K(i) in different individuals can be compared directly without further processing in order to assess the nigrostriatal integrity.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 13 条
  • [1] Familial progressive supranuclear palsy -: Detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography
    Piccini, P
    de Yebenez, J
    Lees, AJ
    Ceravolo, R
    Turjanski, N
    Pramstaller, P
    Brooks, DJ
    ARCHIVES OF NEUROLOGY, 2001, 58 (11) : 1846 - 1851
  • [2] Guidelines for redaction of protocols for positron emission tomography with 6-fluoro-[18F]-L-dihydroxyphenylalanine or 6-fluoro-[18F]-L-DOPA([18F]-FDOPA)
    Bonardel, G.
    Aupee, O.
    Gontier, E.
    Morel, O.
    Montravers, F.
    Bourguignon, M.
    Brunotte, F.
    Petegnief, Y.
    de la Souchere, C. Gibold
    Jacob, T.
    Moati, F.
    Mundler, O.
    Prigent, A.
    Tillon, B.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2011, 35 (12): : 657 - 664
  • [3] HUMAN STRIATAL L-DOPA DECARBOXYLASE ACTIVITY ESTIMATED INVIVO USING 6-[F-18]FLUORO-DOPA AND POSITRON EMISSION TOMOGRAPHY - ERROR ANALYSIS AND APPLICATION TO NORMAL SUBJECTS
    KUWABARA, H
    CUMMING, P
    REITH, J
    LEGER, G
    DIKSIC, M
    EVANS, AC
    GJEDDE, A
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (01): : 43 - 56
  • [4] REGIONAL BRAIN KINETICS OF 6-FLUORO-(BETA-11C)-L-DOPA AND BETA-11C)-L-DOPA FOLLOWING COMT INHIBITION - A STUDY INVIVO USING POSITRON EMISSION TOMOGRAPHY
    HARTVIG, P
    LINDNER, KJ
    TEDROFF, J
    BJURLING, P
    HORNFELT, K
    LANGSTROM, B
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1992, 87 (01) : 15 - 22
  • [5] Brain Alterations and Mini-Mental State Examination in Patients with Progressive Supranuclear Palsy: Voxel-Based Investigations Using F-18-Fluorodeoxyglucose Positron Emission Tomography and Magnetic Resonance Imaging
    Takahashi, Ryuichi
    Ishii, Kazunari
    Kakigi, Tatsuya
    Yokoyama, Kazumasa
    Mori, Etsuro
    Murakami, Takamichi
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 381 - 392
  • [6] Evaluation of the early response and mechanism of treatment of Parkinson's disease with L-dopa using 18F-fallypride micro-positron emission tomography scanning
    Fa, Yi-Hua
    Ni, Jian-Qiang
    Wu, Xiao-Jin
    Tan, Jia-Qing
    Wu, Yi-Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (01) : 101 - 109
  • [7] 6-[F-18]Fluoro-l-DOPA Positron Emission Tomography in the Imaging of Merkel Cell Carcinoma: Preliminary Report of Three Cases with 2-Deoxy-2-[F-18]Fluoro-d-Glucose Positron Emission Tomography or Pentetreotide-(111In) SPECT Data
    Jean-Noël Talbot
    Khaldoun Kerrou
    Filda Missoum
    Dany Grahek
    Nicolas Aide
    Jean Lumbroso
    F. Montravers
    Molecular Imaging and Biology, 2005, 7 : 257 - 261
  • [8] 6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: Preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111ln) SPECT data
    Talbot, JN
    Kerrou, K
    Missoum, F
    Grahek, D
    Aide, N
    Lumbroso, J
    Montravers, F
    MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (04) : 257 - 261
  • [9] 6-[F-18]Fluoro-L-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess
    Fiebrich, Helle-Brit
    Brouwers, Adrienne H.
    Kerstens, Michiel N.
    Pijl, Milan E. J.
    Kema, Ido P.
    de Jong, Johan R.
    Jager, Pieter L.
    Elsinga, Philip H.
    Dierckx, Rudi A. J. O.
    van der Wal, Jacqueline E.
    Sluiter, Wim J.
    de Vries, Elisabeth G. E.
    Links, Thera P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (10): : 3922 - 3930
  • [10] 6-[F-18]FLUORO-L-DOPA UPTAKE AND [BR-76] BROMOLISURIDE BINDING IN THE EXCITOTOXICALLY LESIONED CAUDATE PUTAMEN OF NONHUMAN-PRIMATES STUDIED USING POSITRON EMISSION TOMOGRAPHY
    HANTRAYE, P
    LOCH, C
    MAZIERE, B
    KHALILIVARASTEH, M
    CROUZEL, C
    FOURNIER, D
    YORKE, JC
    STULZAFT, O
    RICHE, D
    ISACSON, O
    MAZIERE, M
    EXPERIMENTAL NEUROLOGY, 1992, 115 (02) : 218 - 227